Zobrazeno 1 - 2
of 2
pro vyhledávání: ''
Autor:
Stig P. Cramer, Henrik Larsson, Jette L. Frederiksen, Helle J. Simonsen, Ian Galea, Aravinthan Varatharaj
Publikováno v:
Annals of Neurology
Cramer, S P, Simonsen, H J, Varatharaj, A, Galea, I, Frederiksen, J L & Larsson, H B W 2018, ' Permeability of the blood–brain barrier predicts no evidence of disease activity at 2 years after natalizumab or fingolimod treatment in relapsing–remitting multiple sclerosis ', Annals of Neurology, vol. 83, no. 5, pp. 902-914 . https://doi.org/10.1002/ana.25219
Cramer, S P, Simonsen, H J, Varatharaj, A, Galea, I, Frederiksen, J L & Larsson, H B W 2018, ' Permeability of the blood–brain barrier predicts no evidence of disease activity at 2 years after natalizumab or fingolimod treatment in relapsing–remitting multiple sclerosis ', Annals of Neurology, vol. 83, no. 5, pp. 902-914 . https://doi.org/10.1002/ana.25219
Objective: To investigate whether blood–brain barrier (BBB) permeability, as measured by dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI), can provide early detection of suboptimal treatment response in relapsing–remitting multiple
Autor:
Reo Saiki, Masafumi Ito, Masashi Tanaka, Hajime Arahata, Shuichi Yatsuga, Yasutoshi Koga, Yoshihiro Fukumoto, Toshio Kojima, Yasunori Fujita, Akiko Ishii, Tatsuyuki Kakuma
Publikováno v:
Annals of Neurology
Objective The diagnosis of mitochondrial disorders (MDs) is occasionally difficult because patients often present with solitary, or a combination of, symptoms caused by each organ insufficiency, which may be the result of respiratory chain enzyme def